Protect Pharmaceutical Corp. (PRTT)
0.25
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Protect Pharmaceutical Net Income (Quarterly) : -0.02M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.02M |
| March 31, 2026 | -0.0015M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 10.06M |
| September 30, 2024 | 26.09M |
| June 30, 2024 | 13.48M |
| March 31, 2024 | 6.701M |
| December 31, 2023 | 14.16M |
| September 30, 2023 | 23.19M |
| June 30, 2023 | 0.647M |
| March 31, 2023 | 7.911M |
| March 31, 2022 | 5.555M |
| December 31, 2021 | 0.00 |
| June 30, 2021 | 0.1891M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.0113M |
| September 30, 2020 | 0.5777M |
| June 30, 2020 | 5.225M |
| March 31, 2020 | -0.0009M |
| September 30, 2019 | -0.0026M |
| June 30, 2019 | -0.0026M |
| June 30, 2018 | -0.0044M |
| March 31, 2018 | -0.0037M |
| December 31, 2017 | -0.0039M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.003M |
| June 30, 2017 | -0.1003M |
| March 31, 2017 | -0.0154M |
| December 31, 2016 | -0.019M |
| September 30, 2016 | -0.0085M |
| June 30, 2016 | -0.0105M |
| March 31, 2016 | -0.0037M |
| December 31, 2015 | -0.0066M |
| September 30, 2015 | -0.6159M |
| June 30, 2015 | -0.0076M |
| March 31, 2015 | -0.0056M |
| December 31, 2014 | 0.4777M |
| September 30, 2014 | -0.0074M |
| June 30, 2014 | -0.0102M |
| March 31, 2014 | -0.002M |
| December 31, 2013 | -0.004M |
| September 30, 2013 | -0.0056M |
| June 30, 2013 | -0.0113M |
| March 31, 2013 | -0.0031M |
| December 31, 2012 | -0.0083M |
| September 30, 2012 | -0.1231M |
| June 30, 2012 | -0.1912M |
| December 31, 2011 | -0.0124M |
| September 30, 2011 | -0.1636M |
| June 30, 2011 | -0.5224M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IGC Pharma, Inc. | -2.936M |
| Cryoport, Inc. | -8.255M |
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.02M |
| EPS Diluted (Quarterly) | -0.0004 |
| Enterprise Value | 14.37M |
| Earnings Yield | 46.00% |
| Normalized Earnings Yield | 46.00 |